DOI QR코드

DOI QR Code

Beyond Attention-Deficit Hyperactivity Disorder: Exploring Psychiatric Comorbidities and Their Neuropsychological Consequences in Adults

  • Hyun Jae Roh (Department of Psychiatry, Nowon Eulji University Hospital, Eulji University School of Medicine) ;
  • Geon Ho Bahn (Department of Psychiatry, Kyung Hee University School of Medicine) ;
  • Seung Yup Lee (Leemind Psychiatric Clinic) ;
  • Yoo-Sook Joung (Department of Psychiatry, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Bongseog Kim (Department of Psychiatry, Inje University College of Medicine) ;
  • Eui-Jung Kim (Department of Psychiatry, College of Medicine, Ewha Womans University) ;
  • Soyoung Irene Lee (Department of Psychiatry, Soonchunhyang University College of Medicine) ;
  • Minha Hong (Department of Psychiatry, Myongji Hospital, Hanyang University College of Medicine) ;
  • Doug Hyun Han (Department of Psychiatry, Chung-Ang University College of Medicine) ;
  • Young Sik Lee (Department of Psychiatry, Chung-Ang University College of Medicine) ;
  • Hanik K Yoo (Department of Clinical Psychiatry, Seoul Brain Research Institute) ;
  • Soo-Young Bhang (Department of Psychiatry, Nowon Eulji University Hospital, Eulji University School of Medicine)
  • Received : 2023.07.24
  • Accepted : 2023.09.05
  • Published : 2023.10.01

Abstract

Objectives: This study aimed to identify the psychiatric comorbidity status of adult patients diagnosed with attention-deficit hyperactivity disorder (ADHD) and determine the impact of comorbidities on neuropsychological outcomes in ADHD. Methods: The study participants were 124 adult patients with ADHD. Clinical psychiatric assessments were performed by two board-certified psychiatrists in accordance with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. All participants were assessed using the Mini-International Neuropsychiatric Interview Plus version 5.0.0 to evaluate comorbidities. After screening, neuropsychological outcomes were assessed using the Comprehensive Attention Test (CAT) and the Korean version of the Wechsler Adult Intelligence Scale, Fourth Edition (K-WAIS-IV). Results: Mood disorders (38.7%) were the most common comorbidity of ADHD, followed by anxiety (18.5%) and substance use disorders (13.7%). The ADHD with comorbidities group showed worse results on the Perceptual Organization Index and Working Memory Index sections of the K-WAIS than the ADHD-alone group (p=0.015 and p=0.024, respectively). In addition, the presence of comorbidities was associated with worse performance on simple visual commission errors in the CAT tests (p=0.024). Conclusion: These findings suggest that psychiatric comorbidities are associated with poor neuropsychological outcomes in adult patients with ADHD, highlighting the need to identify comorbidities in these patients.

Keywords

References

  1. Bitter I, Simon V, Balint S, Meszaros A, Czobor P. How do different diagnostic criteria, age and gender affect the prevalence of attention deficit hyperactivity disorder in adults? An epidemiological study in a Hungarian community sample. Eur Arch Psychiatry Clin Neurosci 2010;260:287-296. https://doi.org/10.1007/s00406-009-0076-3
  2. Lange KW, Reichl S, Lange KM, Tucha L, Tucha O. The history of attention deficit hyperactivity disorder. Atten Defic Hyperact Disord 2010;2:241-255. https://doi.org/10.1007/s12402-010-0045-8
  3. Weyandt LL, Oster DR, Gudmundsdottir BG, DuPaul GJ, Anastopoulos AD. Neuropsychological functioning in college students with and without ADHD. Neuropsychology 2017;31:160-172. https://doi.org/10.1037/neu0000326
  4. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of followup studies. Psychol Med 2006;36:159-165. https://doi.org/10.1017/S003329170500471X
  5. Ramos-Quiroga JA, Montoya A, Kutzelnigg A, Deberdt W, Sobanski E. Attention deficit hyperactivity disorder in the European adult population: prevalence, disease awareness, and treatment guidelines. Curr Med Res Opin 2013;29:1093-1104. https://doi.org/10.1185/03007995.2013.812961
  6. Goksoyr PK, Nottestad JA. The burden of untreated ADHD among adults: the role of stimulant medication. Addict Behav 2008;33:342-346. https://doi.org/10.1016/j.addbeh.2007.09.008
  7. Katzman MA, Bilkey TS, Chokka PR, Fallu A, Klassen LJ. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry 2017;17:302.
  8. Sobanski E, Bruggemann D, Alm B, Kern S, Deschner M, Schubert T, et al. Psychiatric comorbidity and functional impairment in a clinically referred sample of adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2007;257:371-377. https://doi.org/10.1007/s00406-007-0712-8
  9. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry 2006;163:716-723. https://doi.org/10.1176/ajp.2006.163.4.716
  10. Pineiro-Dieguez B, Balanza-Martinez V, Garcia-Garcia P, SolerLopez B; CAT Study Group. Psychiatric comorbidity at the time of diagnosis in adults with ADHD: the CAT study. J Atten Disord 2016;20:1066-1075. https://doi.org/10.1177/1087054713518240
  11. Choi WS, Woo YS, Wang SM, Lim HK, Bahk WM. The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: a systematic literature review. PLoS One 2022;17:e0277175.
  12. Bahn GH, Lee YS, Yoo HK, Kim EJ, Park S, Han DH, et al. Development of the Korean practice parameter for adult attention-deficit/hyperactivity disorder. J Korean Acad Child Adolesc Psychiatry 2020;31:5-25. https://doi.org/10.5765/jkacap.190030
  13. Ortega R, Lopez V, Carrasco X, Escobar MJ, Garcia AM, Parra MA, et al. Neurocognitive mechanisms underlying working memory encoding and retrieval in attention-deficit/hyperactivity disorder. Sci Rep 2020;10:7771.
  14. Willcutt EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry 2005;57:1336-1346. https://doi.org/10.1016/j.biopsych.2005.02.006
  15. Theiling J, Petermann F. Neuropsychological profiles on the WAISIV of adults with ADHD. J Atten Disord 2016;20:913-924. https://doi.org/10.1177/1087054713518241
  16. Hong M, Lee YS, Kim B, Joung YS, Yoo HK, Kim EJ, et al. Clinical utility and cut-off scores of the Korean adult attention-deficit/hyperactivity disorder rating scale. J Korean Acad Child Adolesc Psychiatry 2019;30:116-120. https://doi.org/10.5765/jkacap.190022
  17. Hong M, Kooij JJS, Kim B, Joung YS, Yoo HK, Kim EJ, et al. Validity of the Korean version of DIVA-5: a semi-structured diagnostic interview for adult ADHD. Neuropsychiatr Dis Treat 2020;16:2371-2376. https://doi.org/10.2147/NDT.S262995
  18. Hong JS, Lee YS, Hong M, Kim B, Joung YS, Yoo HK, et al. Cognitive developmental trajectories in adult ADHD patients and controls: a comparative study. J Atten Disord 2022;26:391-407. https://doi.org/10.1177/1087054720978548
  19. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(Suppl 20):22-33; quiz 34-57.
  20. Yoo H, Lee J, Kang SH, Park EH, Jung J, Kim B, et al. Standardization of the comprehensive attention test for the Korean children and adolescents. J Korean Acad Child Adolesc Psychiatry 2009;20:68-75.
  21. Park EH, So YK, Kim YS, Choi NK, Kim SJ, Noh JS, et al. The reliability and validity of Korean conners parent and teacher rating scale. J Korean Acad Child Adolesc Psychiatry 2003;14:183-196.
  22. Mayes SD, Calhoun SL. WISC-IV and WISC-III profiles in children with ADHD. J Atten Disord 2006;9:486-493. https://doi.org/10.1177/1087054705283616
  23. Yeom T, Park Y, Oh K, Kim J, Lee Y. Korean version Wechsler adult intelligence scale. Seoul: Korean Guidance;1992.
  24. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci 2006;256(Suppl 1):i26-i31. https://doi.org/10.1007/s00406-006-1004-4
  25. Seo JC, Jon DI, Shim SH, Sung HM, Woo YS, Hong J, et al. Prevalence and comorbidities of attention deficit hyperactivity disorder among adults and children/adolescents in Korea. Clin Psychopharmacol Neurosci 2022;20:126-134. https://doi.org/10.9758/cpn.2022.20.1.126
  26. Shim SH, Woo YS, Kim JS, Heo IS, Yoon HJ, Sung HM, et al. Comparison between atomoxetine and OROS methylphenidate as an adjunctive to SSRIs in attention-deficit/hyperactivity disorder adults with comorbid partially responsive major depressive disorder: a head-to-head, 12-week, randomized, rater-blinded clinical trial. Clin Psychopharmacol Neurosci 2022;20:143-153. https://doi.org/10.9758/cpn.2022.20.1.143
  27. Nigg JT. Neuropsychologic theory and findings in attention-deficit/hyperactivity disorder: the state of the field and salient challenges for the coming decade. Biol Psychiatry 2005;57:1424-1435. https://doi.org/10.1016/j.biopsych.2004.11.011
  28. Yang CM, Kim BN. The association between attention deficit/hyperactivity disorder symptoms and the number of suicide attempts among male young adults with unipolar and bipolar depression. J Korean Acad Child Adolesc Psychiatry 2020;31:88-93. https://doi.org/10.5765/jkacap.200009